Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-06-01

AUTHORS

Ashham Mansur, Maximilian Steinau, Aron Frederik Popov, Michael Ghadimi, Tim Beissbarth, Martin Bauer, José Hinz

ABSTRACT

BackgroundPrevious investigations have presumed a potential therapeutic effect of statin therapy in patients with acute respiratory distress syndrome (ARDS). Statins are expected to attenuate inflammation in the lungs of patients with ARDS due to their anti-inflammatory effects. Clinical investigations of the role of statin therapy have revealed contradictory results. This study aimed to investigate whether pretreatment and continuous therapy with statins in patients with sepsis-associated ARDS are associated with 28-day survival according to disease severity (mild, moderate, or severe).MethodsPatients with sepsis-associated ARDS from the surgical intensive care were enrolled in this prospective observational investigation. ARDS was classified into three groups (mild, moderate, and severe); 28-day mortality was recorded as the primary outcome variable and organ failure was recorded as secondary outcome variable. Sequential Organ Failure Assessment scores and the requirements for organ support were evaluated throughout the observational period to assess organ failure.Results404 patients with sepsis-associated ARDS were enrolled in this investigation. The distribution of the ARDS subgroups was 13 %, 59 %, and 28 % for mild, moderate, and severe disease, respectively. Statin therapy improved 28-day survival exclusively in the patients with severe ARDS compared with patients without statin therapy (88.5 % and 62.5 %, respectively; P = 0.0193). To exclude the effects of several confounders, we performed multivariate Cox regression analysis, which showed that statin therapy remained a significant covariate for mortality (hazard ratio, 5.46; 95 % CI, 1.38–21.70; P = 0.0156). Moreover, after carrying a propensity score-matching in the severe ARDS cohort, Kaplan-Meier survival analysis confirmed the improved 28-day survival among patients with statin therapy (P = 0.0205). Patients with severe ARDS who received statin therapy had significantly more vasopressor-free days compared with those without statin therapy (13 ± 7 and 9 ± 7, respectively; P = 0.0034), and they also required less extracorporeal membrane oxygenation (ECMO) therapy and had more ECMO-free days (18 ± 9 and 15 ± 9, respectively; P = 0.0873).ConclusionsThis investigation suggests a beneficial effect of continuous statin therapy in patients with severe sepsis-associated ARDS and a history of prior statin therapy. Further study is warranted to elucidate this potential effect. More... »

PAGES

128

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12916-015-0368-6

DOI

http://dx.doi.org/10.1186/s12916-015-0368-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1014024230

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26033076


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kaplan-Meier Estimate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propensity Score", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proportional Hazards Models", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiratory Distress Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sepsis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mansur", 
        "givenName": "Ashham", 
        "id": "sg:person.01314363174.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314363174.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Steinau", 
        "givenName": "Maximilian", 
        "id": "sg:person.01035551111.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035551111.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Cardiothoracic Transplantation & Mechanical Support, Royal Brompton and Harefield Hospital, Harefield, Hill End Road, UB9 6JH, London, UK", 
          "id": "http://www.grid.ac/institutes/grid.439338.6", 
          "name": [
            "Department of Cardiothoracic Transplantation & Mechanical Support, Royal Brompton and Harefield Hospital, Harefield, Hill End Road, UB9 6JH, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Popov", 
        "givenName": "Aron Frederik", 
        "id": "sg:person.01037223774.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037223774.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of General and Visceral Surgery, University Medical Center, Georg August University, D-37075, Goettingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Department of General and Visceral Surgery, University Medical Center, Georg August University, D-37075, Goettingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ghadimi", 
        "givenName": "Michael", 
        "id": "sg:person.01051011043.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051011043.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Statistics, University Medical Center, Georg August University, D-37075, Goettingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Department of Medical Statistics, University Medical Center, Georg August University, D-37075, Goettingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beissbarth", 
        "givenName": "Tim", 
        "id": "sg:person.01251610614.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251610614.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bauer", 
        "givenName": "Martin", 
        "id": "sg:person.015126465640.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015126465640.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.411984.1", 
          "name": [
            "Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hinz", 
        "givenName": "Jos\u00e9", 
        "id": "sg:person.0767340256.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767340256.70"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00134-009-1421-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016986188", 
          "https://doi.org/10.1007/s00134-009-1421-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-008-1358-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008347358", 
          "https://doi.org/10.1007/s00134-008-1358-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.2009.197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017353683", 
          "https://doi.org/10.1038/clpt.2009.197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/cc9403", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039706992", 
          "https://doi.org/10.1186/cc9403"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd1901", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005336052", 
          "https://doi.org/10.1038/nrd1901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-012-2682-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035161920", 
          "https://doi.org/10.1007/s00134-012-2682-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-009-1748-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053690214", 
          "https://doi.org/10.1007/s00134-009-1748-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-005-2859-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025740864", 
          "https://doi.org/10.1007/s00134-005-2859-y"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-06-01", 
    "datePublishedReg": "2015-06-01", 
    "description": "BackgroundPrevious investigations have presumed a potential therapeutic effect of statin therapy in patients with acute respiratory distress syndrome (ARDS). Statins are expected to attenuate inflammation in the lungs of patients with ARDS due to their anti-inflammatory effects. Clinical investigations of the role of statin therapy have revealed contradictory results. This study aimed to investigate whether pretreatment and continuous therapy with statins in patients with sepsis-associated ARDS are associated with 28-day survival according to disease severity (mild, moderate, or severe).MethodsPatients with sepsis-associated ARDS from the surgical intensive care were enrolled in this prospective observational investigation. ARDS was classified into three groups (mild, moderate, and severe); 28-day mortality was recorded as the primary outcome variable and organ failure was recorded as secondary outcome variable. Sequential Organ Failure Assessment scores and the requirements for organ support were evaluated throughout the observational period to assess organ failure.Results404 patients with sepsis-associated ARDS were enrolled in this investigation. The distribution of the ARDS subgroups was 13\u00a0%, 59\u00a0%, and 28\u00a0% for mild, moderate, and severe disease, respectively. Statin therapy improved 28-day survival exclusively in the patients with severe ARDS compared with patients without statin therapy (88.5\u00a0% and 62.5\u00a0%, respectively; P = 0.0193). To exclude the effects of several confounders, we performed multivariate Cox regression analysis, which showed that statin therapy remained a significant covariate for mortality (hazard ratio, 5.46; 95\u00a0% CI, 1.38\u201321.70; P = 0.0156). Moreover, after carrying a propensity score-matching in the severe ARDS cohort, Kaplan-Meier survival analysis confirmed the improved 28-day survival among patients with statin therapy (P = 0.0205). Patients with severe ARDS who received statin therapy had significantly more vasopressor-free days compared with those without statin therapy (13 \u00b1 7 and 9 \u00b1 7, respectively; P = 0.0034), and they also required less extracorporeal membrane oxygenation (ECMO) therapy and had more ECMO-free days (18 \u00b1 9 and 15 \u00b1 9, respectively; P = 0.0873).ConclusionsThis investigation suggests a beneficial effect of continuous statin therapy in patients with severe sepsis-associated ARDS and a history of prior statin therapy. Further study is warranted to elucidate this potential effect.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s12916-015-0368-6", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032885", 
        "issn": [
          "1741-7015"
        ], 
        "name": "BMC Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "keywords": [
      "acute respiratory distress syndrome", 
      "sepsis-associated acute respiratory distress syndrome", 
      "severe acute respiratory distress syndrome", 
      "statin therapy", 
      "respiratory distress syndrome", 
      "distress syndrome", 
      "organ failure", 
      "Sequential Organ Failure Assessment score", 
      "Organ Failure Assessment score", 
      "prospective observational cohort study", 
      "multivariate Cox regression analysis", 
      "extracorporeal membrane oxygenation therapy", 
      "Kaplan-Meier survival analysis", 
      "prospective observational investigation", 
      "vasopressor-free days", 
      "continuous statin therapy", 
      "prior statin therapy", 
      "membrane oxygenation therapy", 
      "observational cohort study", 
      "anti-inflammatory effects", 
      "surgical intensive care", 
      "Cox regression analysis", 
      "primary outcome variable", 
      "lungs of patients", 
      "potential therapeutic effects", 
      "BackgroundPrevious investigations", 
      "ARDS cohort", 
      "continuous therapy", 
      "Secondary outcomes", 
      "cohort study", 
      "oxygenation therapy", 
      "organ support", 
      "intensive care", 
      "therapeutic effect", 
      "severe disease", 
      "clinical investigation", 
      "ARDS severity", 
      "patients", 
      "survival analysis", 
      "therapy", 
      "disease severity", 
      "significant covariates", 
      "assessment scores", 
      "ConclusionsThis investigation", 
      "beneficial effects", 
      "outcome variables", 
      "mortality", 
      "statins", 
      "Further studies", 
      "regression analysis", 
      "survival", 
      "syndrome", 
      "observational period", 
      "severity", 
      "observational investigation", 
      "contradictory results", 
      "days", 
      "potential effects", 
      "MethodsPatients", 
      "inflammation", 
      "failure", 
      "confounders", 
      "lung", 
      "cohort", 
      "disease", 
      "care", 
      "study", 
      "outcomes", 
      "effect", 
      "subgroups", 
      "scores", 
      "covariates", 
      "pretreatment", 
      "group", 
      "investigation", 
      "period", 
      "history", 
      "role", 
      "analysis", 
      "propensity", 
      "support", 
      "variables", 
      "impact", 
      "results", 
      "distribution", 
      "requirements"
    ], 
    "name": "Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study", 
    "pagination": "128", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1014024230"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12916-015-0368-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26033076"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12916-015-0368-6", 
      "https://app.dimensions.ai/details/publication/pub.1014024230"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:58", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_648.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s12916-015-0368-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12916-015-0368-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12916-015-0368-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12916-015-0368-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12916-015-0368-6'


 

This table displays all metadata directly associated to this object as RDF triples.

283 TRIPLES      21 PREDICATES      133 URIs      117 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12916-015-0368-6 schema:about N0e45a23bff984f898be86ee56f0eab64
2 N14187f5e8cc448fea3ca4fa8506890ca
3 N3634ac1dc7e94317b2e5a7bcdcdea2b4
4 N52951077b31b453c8ab88970bceb46af
5 N5f4672dc83174ea9af239fe0d9757b2f
6 N688d5f1138cc488aa241f7e103190158
7 N89534d09ce40434bb43c96f14ba84788
8 N8c92a7b18eea46bfa25686356590c8ac
9 N91ed1a5c99bf42f99baee28eea49f4a4
10 Nb4851bad3f204345a5f9ae8df9b0729c
11 Nbca47d09c61148d1a1ce13144b855dcd
12 Nc021619cb16c42cbafde8e759476fba2
13 Nf83e882c485742f7a481b3a7147a4a70
14 Nfb0c3df3dd8a4b37abc733db5b48c6e8
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author Nf2a2cbd70e5f486c810e5c00c7fafb22
18 schema:citation sg:pub.10.1007/s00134-005-2859-y
19 sg:pub.10.1007/s00134-008-1358-3
20 sg:pub.10.1007/s00134-009-1421-8
21 sg:pub.10.1007/s00134-009-1748-1
22 sg:pub.10.1007/s00134-012-2682-1
23 sg:pub.10.1038/clpt.2009.197
24 sg:pub.10.1038/nrd1901
25 sg:pub.10.1186/cc9403
26 schema:datePublished 2015-06-01
27 schema:datePublishedReg 2015-06-01
28 schema:description BackgroundPrevious investigations have presumed a potential therapeutic effect of statin therapy in patients with acute respiratory distress syndrome (ARDS). Statins are expected to attenuate inflammation in the lungs of patients with ARDS due to their anti-inflammatory effects. Clinical investigations of the role of statin therapy have revealed contradictory results. This study aimed to investigate whether pretreatment and continuous therapy with statins in patients with sepsis-associated ARDS are associated with 28-day survival according to disease severity (mild, moderate, or severe).MethodsPatients with sepsis-associated ARDS from the surgical intensive care were enrolled in this prospective observational investigation. ARDS was classified into three groups (mild, moderate, and severe); 28-day mortality was recorded as the primary outcome variable and organ failure was recorded as secondary outcome variable. Sequential Organ Failure Assessment scores and the requirements for organ support were evaluated throughout the observational period to assess organ failure.Results404 patients with sepsis-associated ARDS were enrolled in this investigation. The distribution of the ARDS subgroups was 13 %, 59 %, and 28 % for mild, moderate, and severe disease, respectively. Statin therapy improved 28-day survival exclusively in the patients with severe ARDS compared with patients without statin therapy (88.5 % and 62.5 %, respectively; P = 0.0193). To exclude the effects of several confounders, we performed multivariate Cox regression analysis, which showed that statin therapy remained a significant covariate for mortality (hazard ratio, 5.46; 95 % CI, 1.38–21.70; P = 0.0156). Moreover, after carrying a propensity score-matching in the severe ARDS cohort, Kaplan-Meier survival analysis confirmed the improved 28-day survival among patients with statin therapy (P = 0.0205). Patients with severe ARDS who received statin therapy had significantly more vasopressor-free days compared with those without statin therapy (13 ± 7 and 9 ± 7, respectively; P = 0.0034), and they also required less extracorporeal membrane oxygenation (ECMO) therapy and had more ECMO-free days (18 ± 9 and 15 ± 9, respectively; P = 0.0873).ConclusionsThis investigation suggests a beneficial effect of continuous statin therapy in patients with severe sepsis-associated ARDS and a history of prior statin therapy. Further study is warranted to elucidate this potential effect.
29 schema:genre article
30 schema:isAccessibleForFree true
31 schema:isPartOf N74b2a73479ae4e2d9843397746d0a6a0
32 Nafcb0480a1d64cb28a6113c979b722e2
33 sg:journal.1032885
34 schema:keywords ARDS cohort
35 ARDS severity
36 BackgroundPrevious investigations
37 ConclusionsThis investigation
38 Cox regression analysis
39 Further studies
40 Kaplan-Meier survival analysis
41 MethodsPatients
42 Organ Failure Assessment score
43 Secondary outcomes
44 Sequential Organ Failure Assessment score
45 acute respiratory distress syndrome
46 analysis
47 anti-inflammatory effects
48 assessment scores
49 beneficial effects
50 care
51 clinical investigation
52 cohort
53 cohort study
54 confounders
55 continuous statin therapy
56 continuous therapy
57 contradictory results
58 covariates
59 days
60 disease
61 disease severity
62 distress syndrome
63 distribution
64 effect
65 extracorporeal membrane oxygenation therapy
66 failure
67 group
68 history
69 impact
70 inflammation
71 intensive care
72 investigation
73 lung
74 lungs of patients
75 membrane oxygenation therapy
76 mortality
77 multivariate Cox regression analysis
78 observational cohort study
79 observational investigation
80 observational period
81 organ failure
82 organ support
83 outcome variables
84 outcomes
85 oxygenation therapy
86 patients
87 period
88 potential effects
89 potential therapeutic effects
90 pretreatment
91 primary outcome variable
92 prior statin therapy
93 propensity
94 prospective observational cohort study
95 prospective observational investigation
96 regression analysis
97 requirements
98 respiratory distress syndrome
99 results
100 role
101 scores
102 sepsis-associated acute respiratory distress syndrome
103 severe acute respiratory distress syndrome
104 severe disease
105 severity
106 significant covariates
107 statin therapy
108 statins
109 study
110 subgroups
111 support
112 surgical intensive care
113 survival
114 survival analysis
115 syndrome
116 therapeutic effect
117 therapy
118 variables
119 vasopressor-free days
120 schema:name Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study
121 schema:pagination 128
122 schema:productId N39e8bbd54b6d4166a0e7c29ab49b06aa
123 N983a732706d74679a2b26b356b1da7ff
124 Nfa2508c1cd0a41fda5a44cc9b3d317d1
125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014024230
126 https://doi.org/10.1186/s12916-015-0368-6
127 schema:sdDatePublished 2022-11-24T20:58
128 schema:sdLicense https://scigraph.springernature.com/explorer/license/
129 schema:sdPublisher N2cfcf14f9f4846ab8a4cbf784a532385
130 schema:url https://doi.org/10.1186/s12916-015-0368-6
131 sgo:license sg:explorer/license/
132 sgo:sdDataset articles
133 rdf:type schema:ScholarlyArticle
134 N0cdfad31ab91427da56151aac8c75734 rdf:first sg:person.0767340256.70
135 rdf:rest rdf:nil
136 N0e45a23bff984f898be86ee56f0eab64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Prospective Studies
138 rdf:type schema:DefinedTerm
139 N14187f5e8cc448fea3ca4fa8506890ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Propensity Score
141 rdf:type schema:DefinedTerm
142 N200849cf77824105b5fafe754d6b5ca3 rdf:first sg:person.01251610614.75
143 rdf:rest Nee45749bff374d21a182ea1c22766767
144 N2cfcf14f9f4846ab8a4cbf784a532385 schema:name Springer Nature - SN SciGraph project
145 rdf:type schema:Organization
146 N3634ac1dc7e94317b2e5a7bcdcdea2b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Male
148 rdf:type schema:DefinedTerm
149 N39e8bbd54b6d4166a0e7c29ab49b06aa schema:name doi
150 schema:value 10.1186/s12916-015-0368-6
151 rdf:type schema:PropertyValue
152 N4b6a9f6d46914ab8887474e9d5360e26 rdf:first sg:person.01051011043.33
153 rdf:rest N200849cf77824105b5fafe754d6b5ca3
154 N52951077b31b453c8ab88970bceb46af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Proportional Hazards Models
156 rdf:type schema:DefinedTerm
157 N5f4672dc83174ea9af239fe0d9757b2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Humans
159 rdf:type schema:DefinedTerm
160 N688d5f1138cc488aa241f7e103190158 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Adult
162 rdf:type schema:DefinedTerm
163 N74b2a73479ae4e2d9843397746d0a6a0 schema:issueNumber 1
164 rdf:type schema:PublicationIssue
165 N89534d09ce40434bb43c96f14ba84788 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Aged
167 rdf:type schema:DefinedTerm
168 N8c92a7b18eea46bfa25686356590c8ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Kaplan-Meier Estimate
170 rdf:type schema:DefinedTerm
171 N91ed1a5c99bf42f99baee28eea49f4a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Female
173 rdf:type schema:DefinedTerm
174 N983a732706d74679a2b26b356b1da7ff schema:name dimensions_id
175 schema:value pub.1014024230
176 rdf:type schema:PropertyValue
177 Nafcb0480a1d64cb28a6113c979b722e2 schema:volumeNumber 13
178 rdf:type schema:PublicationVolume
179 Nb15a2ee8ca214747bdda1c679d6e1bdb rdf:first sg:person.01035551111.98
180 rdf:rest Nf88a04f96ffb4de39111b3b17c5f13d0
181 Nb4851bad3f204345a5f9ae8df9b0729c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Sepsis
183 rdf:type schema:DefinedTerm
184 Nbca47d09c61148d1a1ce13144b855dcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Cohort Studies
186 rdf:type schema:DefinedTerm
187 Nc021619cb16c42cbafde8e759476fba2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Respiratory Distress Syndrome
189 rdf:type schema:DefinedTerm
190 Nee45749bff374d21a182ea1c22766767 rdf:first sg:person.015126465640.34
191 rdf:rest N0cdfad31ab91427da56151aac8c75734
192 Nf2a2cbd70e5f486c810e5c00c7fafb22 rdf:first sg:person.01314363174.29
193 rdf:rest Nb15a2ee8ca214747bdda1c679d6e1bdb
194 Nf83e882c485742f7a481b3a7147a4a70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Middle Aged
196 rdf:type schema:DefinedTerm
197 Nf88a04f96ffb4de39111b3b17c5f13d0 rdf:first sg:person.01037223774.58
198 rdf:rest N4b6a9f6d46914ab8887474e9d5360e26
199 Nfa2508c1cd0a41fda5a44cc9b3d317d1 schema:name pubmed_id
200 schema:value 26033076
201 rdf:type schema:PropertyValue
202 Nfb0c3df3dd8a4b37abc733db5b48c6e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Hydroxymethylglutaryl-CoA Reductase Inhibitors
204 rdf:type schema:DefinedTerm
205 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
206 schema:name Medical and Health Sciences
207 rdf:type schema:DefinedTerm
208 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
209 schema:name Clinical Sciences
210 rdf:type schema:DefinedTerm
211 sg:journal.1032885 schema:issn 1741-7015
212 schema:name BMC Medicine
213 schema:publisher Springer Nature
214 rdf:type schema:Periodical
215 sg:person.01035551111.98 schema:affiliation grid-institutes:grid.411984.1
216 schema:familyName Steinau
217 schema:givenName Maximilian
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01035551111.98
219 rdf:type schema:Person
220 sg:person.01037223774.58 schema:affiliation grid-institutes:grid.439338.6
221 schema:familyName Popov
222 schema:givenName Aron Frederik
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037223774.58
224 rdf:type schema:Person
225 sg:person.01051011043.33 schema:affiliation grid-institutes:grid.411984.1
226 schema:familyName Ghadimi
227 schema:givenName Michael
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051011043.33
229 rdf:type schema:Person
230 sg:person.01251610614.75 schema:affiliation grid-institutes:grid.411984.1
231 schema:familyName Beissbarth
232 schema:givenName Tim
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251610614.75
234 rdf:type schema:Person
235 sg:person.01314363174.29 schema:affiliation grid-institutes:grid.411984.1
236 schema:familyName Mansur
237 schema:givenName Ashham
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01314363174.29
239 rdf:type schema:Person
240 sg:person.015126465640.34 schema:affiliation grid-institutes:grid.411984.1
241 schema:familyName Bauer
242 schema:givenName Martin
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015126465640.34
244 rdf:type schema:Person
245 sg:person.0767340256.70 schema:affiliation grid-institutes:grid.411984.1
246 schema:familyName Hinz
247 schema:givenName José
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767340256.70
249 rdf:type schema:Person
250 sg:pub.10.1007/s00134-005-2859-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1025740864
251 https://doi.org/10.1007/s00134-005-2859-y
252 rdf:type schema:CreativeWork
253 sg:pub.10.1007/s00134-008-1358-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008347358
254 https://doi.org/10.1007/s00134-008-1358-3
255 rdf:type schema:CreativeWork
256 sg:pub.10.1007/s00134-009-1421-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016986188
257 https://doi.org/10.1007/s00134-009-1421-8
258 rdf:type schema:CreativeWork
259 sg:pub.10.1007/s00134-009-1748-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053690214
260 https://doi.org/10.1007/s00134-009-1748-1
261 rdf:type schema:CreativeWork
262 sg:pub.10.1007/s00134-012-2682-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035161920
263 https://doi.org/10.1007/s00134-012-2682-1
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/clpt.2009.197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017353683
266 https://doi.org/10.1038/clpt.2009.197
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/nrd1901 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005336052
269 https://doi.org/10.1038/nrd1901
270 rdf:type schema:CreativeWork
271 sg:pub.10.1186/cc9403 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039706992
272 https://doi.org/10.1186/cc9403
273 rdf:type schema:CreativeWork
274 grid-institutes:grid.411984.1 schema:alternateName Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany
275 Department of General and Visceral Surgery, University Medical Center, Georg August University, D-37075, Goettingen, Germany
276 Department of Medical Statistics, University Medical Center, Georg August University, D-37075, Goettingen, Germany
277 schema:name Department of Anesthesiology, University Medical Center, Georg August University, D-37075, Goettingen, Germany
278 Department of General and Visceral Surgery, University Medical Center, Georg August University, D-37075, Goettingen, Germany
279 Department of Medical Statistics, University Medical Center, Georg August University, D-37075, Goettingen, Germany
280 rdf:type schema:Organization
281 grid-institutes:grid.439338.6 schema:alternateName Department of Cardiothoracic Transplantation & Mechanical Support, Royal Brompton and Harefield Hospital, Harefield, Hill End Road, UB9 6JH, London, UK
282 schema:name Department of Cardiothoracic Transplantation & Mechanical Support, Royal Brompton and Harefield Hospital, Harefield, Hill End Road, UB9 6JH, London, UK
283 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...